interleukin-6 inhibitors (Schering-Plough)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinterleukin-6 inhibitors (Schering-Plough)
Drug Alias NameIL-6 inhibitors (Schering-Plough)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIL-6 receptor antagonists
TargetsIL-6 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough Corp
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A